Aperio Group, LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.9%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$50,000
+108.3%
14,548
+280.4%
0.00%
Q2 2019$24,000
-85.5%
3,824
-75.4%
0.00%
-100.0%
Q3 2018$166,000
-14.0%
15,540
-3.2%
0.00%0.0%
Q2 2018$193,000
+17.0%
16,052
-16.7%
0.00%0.0%
Q1 2018$165,000
+29.9%
19,270
+49.5%
0.00%0.0%
Q4 2017$127,00012,8930.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders